Grimes & Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.58M | Sell |
13,129
-256
| -2% | -$123K | 0.14% | 103 |
|
|
2026
Q1 | $6.58M | Sell |
13,385
-402
| -3% | -$218K | 0.18% | 97 |
|
|
2025
Q4 | $7.99M | Sell |
13,787
-747
| -5% | -$422K | 0.19% | 92 |
|
|
2025
Q3 | $7.05M | Sell |
14,534
-1,609
| -10% | -$749K | 0.17% | 96 |
|
|
2025
Q2 | $6.55M | Buy |
16,143
+144
| +0.9% | +$60.2K | 0.18% | 105 |
|
|
2025
Q1 | $7.96M | Buy |
15,999
+1,609
| +11% | +$871K | 0.25% | 89 |
|
|
2024
Q4 | $7.49M | Buy |
14,390
+12,000
| +502% | +$6.6M | 0.22% | 89 |
|
|
2024
Q3 | $1.48M | Buy |
2,390
+74
| +3% | +$43.8K | 0.04% | 159 |
|
|
2024
Q2 | $1.28M | Buy |
2,316
+33
| +1% | +$18.9K | 0.04% | 160 |
|
|
2024
Q1 | $1.33M | Sell |
2,283
-7
| -0.3% | -$3.93K | 0.04% | 160 |
|
|
2023
Q4 | $1.22M | Sell |
2,290
-30
| -1% | -$14.5K | 0.04% | 158 |
|
|
2023
Q3 | $1.17M | Sell |
2,320
-55
| -2% | -$29.3K | 0.05% | 149 |
|
|
2023
Q2 | $1.24M | Buy |
2,375
+74
| +3% | +$39.9K | 0.04% | 145 |
|
|
2023
Q1 | $1.33M | Hold |
2,301
| – | – | 0.05% | 136 |
|
|
2022
Q4 | $1.27M | Buy |
2,301
+639
| +38% | +$339K | 0.05% | 146 |
|
|
2022
Q3 | $844K | Sell |
1,662
-8
| -0.5% | -$4.48K | 0.04% | 154 |
|
|
2022
Q2 | $907K | Buy |
1,670
+250
| +18% | +$138K | 0.05% | 154 |
|
|
2022
Q1 | $839K | Buy |
1,420
+18
| +1% | +$10.3K | 0.04% | 167 |
|
|
2021
Q4 | $935K | Buy |
1,402
+22
| +2% | +$13.7K | 0.04% | 167 |
|
|
2021
Q3 | $789K | Buy |
1,380
+29
| +2% | +$15.9K | 0.03% | 173 |
|
|
2021
Q2 | $682K | Sell |
1,351
-15
| -1% | -$7.08K | 0.03% | 181 |
|
|
2021
Q1 | $623K | Sell |
1,366
-18
| -1% | -$8.59K | 0.03% | 177 |
|
|
2020
Q4 | $645K | Hold |
1,384
| – | – | 0.03% | 172 |
|
|
2020
Q3 | $612K | Buy |
1,384
+50
| +4% | +$20.7K | 0.04% | 167 |
|
|
2020
Q2 | $484K | Buy |
1,334
+3
| +0.2% | +$1.01K | 0.03% | 177 |
|
|
2020
Q1 | $378K | Hold |
1,331
| – | – | 0.03% | 182 |
|
|
2019
Q4 | $433K | Buy |
1,331
+235
| +21% | +$71.3K | 0.03% | 190 |
|
|
2019
Q3 | $320K | Buy |
1,096
+2
| +0.2% | +$573 | 0.02% | 200 |
|
|
2019
Q2 | $322K | Hold |
1,094
| – | – | 0.02% | 199 |
|
|
2019
Q1 | $299K | Buy |
1,094
+172
| +19% | +$42.8K | 0.02% | 203 |
|
|
2018
Q4 | $206K | Sell |
922
-118
| -11% | -$27.7K | 0.02% | 219 |
|
|
2018
Q3 | $254K | Buy |
1,040
+25
| +2% | +$5.75K | 0.02% | 208 |
|
|
2018
Q2 | $210K | Hold |
1,015
| – | – | 0.02% | 222 |
|
|
2018
Q1 | $210K | Buy |
+1,015
| New | +$213K | 0.02% | 222 |
|
Other funds holding TMO
RG
ECSS
LT
Grimes & Company's TMO Position: Q2 2026 in Review
Grimes & Company reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $123K and leaving 13,129 shares worth $6.58M. The position accounts for 0.14% of the portfolio, ranked #103.
Grimes & Company first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. The position peaked at $7.99M in Q4 2025. 1,109 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Grimes & Company held 13,129 shares of Thermo Fisher Scientific worth $6.58M as of Q2 2026.
- Grimes & Company sold 256 Thermo Fisher Scientific shares in Q2 2026, an estimated $123K.
- Thermo Fisher Scientific made up 0.14% of Grimes & Company's portfolio in Q2 2026, its #103 holding.
- Grimes & Company first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- Grimes & Company's Thermo Fisher Scientific position peaked at $7.99M in Q4 2025.
- 1,109 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.